Though many areas of the world are seeing an increase in childhood obesity rates, Amsterdam has cut the number of overweight and obese children by 12 percent through city-wide “healthy-weight program" that has kids weighed regularly and tested for balance and agility.

Both men and women over the age of 50 have reduced their risk factors for heart disease and stroke over a 20-year period, according to a new study published online March 22 in Aging Clinical and Experimental Research.

Individuals who consume large amounts of meat protein experience a 60 percent increase in cardiovascular disease (CVD), according to research published in the International Journal of Epidemiology on April 3.

The YMCA and American Heart Association (AHA) are launching a collaborative effort this spring to help combat hypertension. Through the new partnership, clinics participating in the AHA and American Medical Association’s national Target: BP initiative can refer patients to the YMCA for free support in learning how to self-monitor their blood pressure.

The Dexcom G6 continuous glucose monitoring (CGM) system received FDA marketing approval March 27, the agency announced. This is the first system permitted by the FDA to be used in an “integrated” fashion alongside other diabetes management devices, including automatic insulin dosing systems, insulin pumps and blood glucose meters.

Individuals whose diets are rich in plant-based monounsaturated fatty acids are associated with a lower risk of dying from heart disease or other causes in comparison to animal-based diets rich in monounsaturated fats, according to preliminary findings presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 on March 21 in New Orleans.

BOCA RATON, Fla., March 27, 2018 — New research from MDVIP and Cleveland HeartLab finds that patients with diabetes, pre-diabetes or no evidence of diabetes whose physicians ordered myeloperoxidase (MPO) inflammation testing achieved sharp reductions in MPO levels over five years.

Though a significant amount of literature currently exists regarding high cholesterol as a risk factor for cardiovascular disease (CVD), less than 40 percent of people with high cholesterol levels are prescribed the correct drug treatments, according to new research published in the American Heart Association’s journal Circulation.